Patents
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
07/2009
07/14/2009US7560242 Metadherin polypeptides, encoding nucleic acids and methods of use
07/14/2009US7560118 Attenuated dengue virus comprising mutations in the NS3 gene
07/14/2009US7560117 Comprises protease-reverse transcriptase polyprotein with enhanced polymerase and reduced proteolytic activities for use in identifying inhibitors of viral infection; enzyme inhibitors; viricides
07/14/2009US7560116 Compositions, methods and kits relating to poxvirus subunit vaccines
07/14/2009US7560113 Inactivating organisms using carbon dioxide at or near its supercritical pressure and temperature conditions
07/14/2009US7560112 Anti-il-6 antibodies, compositions, methods and uses
07/14/2009US7560111 HER2 antibody composition
07/14/2009US7560110 Radioimmunotherapy; antibody fragment having at least one arm that specifically binds a targeted tissue and at least one other arm that specifically binds a targetable construct
07/14/2009US7560109 Immunogen adherence inhibitor directed to lactic acid producing organisms and method of making and using it
07/14/2009US7560108 Anti-TNFα antibodies
07/14/2009US7560105 Dendritic cells activated in the presence of glucocorticoid hormones are capable of suppressing antigen-specific T cell responses
07/14/2009US7560104 For use as vaccines for in vivo immunotherapy
07/14/2009US7560103 Administering hapten modified syngeneic human tumor cell substantially in a no growth phase and an adjuvant for therapy of cancer
07/14/2009US7560102 Method for reducing neuronal degeneration so as to ameliorate the effects of injury or disease
07/14/2009US7560101 Method of treatment of an infection in an animal with GM-CSF cysteine muteins in the proximal region to helix A
07/14/2009US7560095 Cancer specific monoclonal antibodies
07/14/2009CA2439858C Graft rejection suppressors
07/14/2009CA2382302C A nucleic acid and encoding polypeptide for use in inhibiting tumor angiogenesis
07/14/2009CA2331410C Methods for treating diabetes by inhibiting gdf-8
07/09/2009WO2009086552A1 Targeting recombinant therapeutics to circulating red blood cells
07/09/2009WO2009086539A2 Treatment and prophylaxis of amyloidosis
07/09/2009WO2009086514A1 Humanized monoclonal antibodies and methods of use
07/09/2009WO2009086284A1 Cd24 as a brain tumor stem cell marker and a diagnostic and therapeutic target in primary neaural and glial tumors of the brain
07/09/2009WO2009086203A2 Method and apparatus for increasing contaminant clearance rates during extracorporeal fluid treatment
07/09/2009WO2009086072A2 Therapy of rituximab-refractory rheumatoid arthritis patients
07/09/2009WO2009086062A1 Stabilized formulations of peptides and proteins
07/09/2009WO2009086003A1 Methods for the treatment of gout
07/09/2009WO2009085920A1 Fdf03 antibodies and uses thereof
07/09/2009WO2009085475A1 Method for detection and treatment of aneurysms
07/09/2009WO2009085313A1 Preparations and methods for treating malignancies
07/09/2009WO2009085262A1 Method of treating cancer with immunomodulatory compounds and igg
07/09/2009WO2009085209A2 Methods for using and identifying modulators of delta-like 4
07/09/2009WO2009085200A2 Anti-amyloid antibodies and uses thereof
07/09/2009WO2009085025A2 System and method for sparql-query processing using parametrized-sparql-query in dbms-based systems
07/09/2009WO2009084671A1 Human anti-α9 integrin antibody
07/09/2009WO2009084659A1 Solution preparation containing antibody at high concentration
07/09/2009WO2009083755A1 Use of t cells expressing cd16 receptors for enhancing the antibody-dependent cellular cytotoxiciy (adcc)
07/09/2009WO2009083602A1 B-cell depleting agents, like anti-cd20 antibodies or fragments thereof for the treatment of chronic fatigue syndrome
07/09/2009WO2009083589A1 Pharmaceutical formulation for allergen preparation
07/09/2009WO2009083246A1 Antibodies to tnf alpha
07/09/2009WO2009083210A1 Replication-defective arenavirus vectors
07/09/2009WO2009083009A2 Monoclonal antibodies against cd32b
07/09/2009WO2009020933A9 Therapeutic use of anti-tweak receptor antibodies
07/09/2009WO2008154251A4 C3b antibodies and methods for the prevention and treatment of complement- associated disorders
07/09/2009WO2008141511A8 A HUMAN ANTI-TNFα MONOCLONAL ANTIBODY AND THE USE THEREOF
07/09/2009WO2008132134A9 Novel antibody molecules and nucleic acids binding to fungal stress protein hsp90
07/09/2009WO2008090355A3 Inhibitors of stem cells markers
07/09/2009WO2008054431A3 Anti-hyperproliferative therapies targeting hdgf
07/09/2009WO2008044824A9 Antibodies to ip-10 for treating bone diseases with bone destruction
07/09/2009WO2008044149A8 Shigella ipad protein and its use as a vaccine against shigella infection
07/09/2009WO2008034388A8 Virus-like particles of capsid proteins from human papillomavirus type 16/58/18/6/11 and the method for preparation and the uses thereof
07/09/2009WO2008024919A8 Interferon antagonists, antibodies thereto, and associated methods of use
07/09/2009WO2005004791A3 Compounds and methods for the treatment and prevention of bacterial infection
07/09/2009US20090176973 Thrombopoietin mimetics
07/09/2009US20090176966 Natural IGM Antibodies and Inhibitors Thereof
07/09/2009US20090176874 Tnp-470 polymer conjugates and use thereof
07/09/2009US20090176746 4'-{N'-[1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-3'-hydroxybiphenyl-4-carboxylic acid; Promotes thrombopoiesis and megakaryocytopoiesis
07/09/2009US20090176707 Human signal peptide-containing proteins
07/09/2009US20090176302 Modified Mite Allergen and Pharmaceutical uses Thereof
07/09/2009US20090176276 Fusion Polypeptides of Human Serum Albumin and a Therapeutically Active Polypeptide
07/09/2009US20090176200 Modified Human Hepatitis C Virus Genomic RNA That can be Autonomously Replicated
07/09/2009US20090175943 Transdiscal administration of specific inhibitors of pro-inflammatory cytokines
07/09/2009US20090175923 Humanized anti-amyloid beta antibodies
07/09/2009US20090175913 Ammendola/salmonella enterica strains of reduced pathogenicity, method for their preparation and uses thereof
07/09/2009US20090175912 chimeric proteins; immunogens; from non-typeable Haemophilus influenzae or Moraxella catarrhalis, provides protective antigens in single molecule; inserting into surface exposed loops improves detection by immune system
07/09/2009US20090175911 Bacterial Production of Carotenoids
07/09/2009US20090175910 Modifications of HIV Env, Gag, and Pol enhance immunogenicity for genetic immunization
07/09/2009US20090175909 Influenza Hemagglutinin And Neuraminidase Variants
07/09/2009US20090175908 Influenza Hemagglutinin And Neuraminidase Variants
07/09/2009US20090175907 Multi Plasmid System For The Production Of Influenza Virus
07/09/2009US20090175906 Genetically Modified Attenuated Vesicular Stomatitis Virus, Compositions and Methods of use Thereof
07/09/2009US20090175905 Transfection reagent and method for enhancing transfection efficiency
07/09/2009US20090175904 Expressing hepatitis B virus surface antigen for vaccine preparation
07/09/2009US20090175903 Measles subunit vaccine
07/09/2009US20090175902 Immunogenic Substances Comprising A Polyinosinic Acid-Polycytidilic Acid Based Adjuvant
07/09/2009US20090175901 Immunostimulatory recombinant intracellular pathogen immunogenic compositions and methods of use
07/09/2009US20090175900 Methods for packaging propagation-defective vesicular stomatitis virus vectors
07/09/2009US20090175899 Recombinant rsv virus expression systems and vaccines
07/09/2009US20090175898 Influenza Hemagglutinin And Neuraminidase Variants
07/09/2009US20090175897 System for rapid production of high-titer and replication-competent adenovirus-free recombinant adenovirus vectors
07/09/2009US20090175896 CAT Allergen Conjugates and Uses Thereof
07/09/2009US20090175895 Methods and compositions for treating and preventing malaria
07/09/2009US20090175894 Methods and materials for producing a generic anti-amyloid immune response in mammals
07/09/2009US20090175893 Albumin-Fused Anti-Angiogenesis Peptides
07/09/2009US20090175892 Polynucleotides encoding MHC class I-restricted hTERT epitopes, analogues thereof or polyepitopes
07/09/2009US20090175891 Preventive And Therapeutic Vaccine For Huntington's Disease
07/09/2009US20090175890 Use of immature dendritic cells to silence antigen specific cd8+ t cell function
07/09/2009US20090175889 Hiv vaccine
07/09/2009US20090175888 Methods of treating cancer with an antibody-drug conjugate
07/09/2009US20090175887 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
07/09/2009US20090175886 Monoclonal antibodies against cd30 lacking in fucosyl and xylosyl residues
07/09/2009US20090175885 Method of controlling insect pests in cotton
07/09/2009US20090175884 Misfolded proteins in cancer treatment and diagnosis
07/09/2009US20090175883 Stabilized anti-respiratory syncytial virus (RSV) antibody formulations
07/09/2009US20090175882 Methods and compositions for treating hyperalgesia
07/09/2009US20090175881 Interleukin-17A specific immunoglobulin for use in prevention and treatment of inflammatory, autoimmune and proliferative disorders
07/09/2009US20090175880 Antibodies that bind human dendritic and epithelial cell 205 (dec-205)
07/09/2009US20090175879 Novel target in the treatment of cytokine release syndrome
07/09/2009US20090175878 Cerebral Vasospasm Inhibitor
07/09/2009US20090175877 Methods of inhibiting metastasis